Baxter International Inc. vs. Pulse Biosciences, Inc Common Stock (DE)
BAX
Baxter International Inc.
$22.80 -0.96%
VS PLSEPulse Biosciences, Inc Common Stock (DE)
$53.87 +6.44%
Baxter International Inc. (BAX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BAX | PLSE | |
|---|---|---|
| Market Cap | $11.79 billion | $3.84 billion |
| Revenue (TTM) | $11.47 billion | $1.19 million |
| Net Income (TTM) | $-1,063,000,000 | $-80,056,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | PLSE | |
|---|---|---|
| Price / Book | 1.91 | 38.61 |
| Price / Sales | 1.03 | 3242.32 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | PLSE | |
|---|---|---|
| Net Margin | -9.27% | -6755.78% |
| Return on Equity | -17.20% | -80.46% |
BAX leads on 2 of 2 profitability factors.
Dividend
| BAX | PLSE | |
|---|---|---|
| Dividend Yield | 0.18% | — |
BAX and PLSE split the dividend factors evenly.
Risk & Sentiment
| BAX | PLSE | |
|---|---|---|
| Short Interest | 1.03% | 2.24% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, PLSE overview, PLSE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.